Literature DB >> 1357552

Treatment for Alzheimer's disease?

J H Growdon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1357552     DOI： 10.1056/NEJM199210293271810

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Effects of scopolamine on learning and memory in monkeys.

Authors:  U C Savage; W B Faust; P Lambert; J M Moerschbaecher
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Authors:  F P Zemlan
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Long-term course and effectiveness of combination therapy in Alzheimer disease.

Authors:  Alireza Atri; Lynn W Shaughnessy; Joseph J Locascio; John H Growdon
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

4.  Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.

Authors:  D K Lahiri; M R Farlow
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 5.  Neuropathobiology of senile dementia and mechanism of action of nootropic drugs.

Authors:  O Benesová
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 6.  New treatments for dementia. Myth, magic, and science.

Authors:  R Ganesan; T Standish; D W Molloy; P Darzins; J B Orange
Journal:  Can Fam Physician       Date:  1994-06       Impact factor: 3.275

7.  The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.

Authors:  N H Holford; K Peace
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of tacrine.

Authors:  S Madden; V Spaldin; B K Park
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.